DNA sequence variations of the entire anti-Müllerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer–Rokitanski–Küster–Hauser syndrome
Open Access
- 1 January 2005
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 20 (1), 149-157
- https://doi.org/10.1093/humrep/deh547
Abstract
BACKGROUND: The etiology of the Mayer–Rokitanski–Küster–Hauser (MRKH) syndrome, where congenitally the Müllerian ducts fail to develop into the uterus, cervix and upper vagina, along with other malformations, is unresolved. Anti-Müllerian hormone (AMH) signal transduction inducing the degradation of Müllerian ducts in males is implicated in the MRKH syndrome. This study examined if DNA sequence variations are responsible for the activation of AMH and aberrant hormone levels in MRKH patients. METHODS: The entire AMH promoter and 3′ regulatory elements of the constitutively expressed splicing factor SF3a2 were sequenced in 30 MRKH patients and genotyped in 48 control individuals using matrix-assisted laser desorption/ionization-time-of-flight mass spectronomy. Ovarian AMH promoter function was correlated with protein expression in plasma and peritoneal fluid of MRKH patients. RESULTS: Of six identified AMH promoter variations, two at positions −639 (SP1-binding site) and −210 [steroidogenic factor (SF)1-binding site] were homozygote in 73% of patients, and 69% of control individuals, destroying the SP1-binding site. AMH protein levels in plasma and peritoneal fluid from patients were equivalent to control individuals, however in three patients plasma levels were abnormally high. CONCLUSIONS: AMH is an important indicator for ovarian function. AMH promoter sequence variations or the previously proposed SF3a2-AMH fusion co-transcripts cannot be responsible for aberrant AMH expression leading to Müllerian duct degradation.Keywords
This publication has 34 references indexed in Scilit:
- Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190 562 genetic variations in the human genomeJournal of Human Genetics, 2002
- A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer riskProceedings of the National Academy of Sciences, 2002
- Targeted Mutagenesis of the Endogenous Mouse Mis Gene PromoterCell, 1999
- Vaginal agenesis (Mayer-Rokitansky-Kuster-Hauser Syndrome) associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT)Molecular Human Reproduction, 1996
- Insensitivity to anti–Müllerian hormone due to a mutation in the human anti–Müllerian hormone receptorNature Genetics, 1995
- The genes for a spliceosome protein (SAP62) and the anti-Müllerian hormone (AMH) are contiguousHuman Molecular Genetics, 1995
- Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related geneNature, 1994
- Correspondence Between a Mammalian Spliceosome Component and an Essential Yeast Splicing FactorScience, 1993
- Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substanceNature, 1990
- The MURCS association: Müllerian duct aplasia, renal aplasia, and cervicothoracic somite dysplasiaThe Journal of Pediatrics, 1979